234 related articles for article (PubMed ID: 17566595)
1. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug.
Hanafy A; Spahn-Langguth H; Vergnault G; Grenier P; Tubic Grozdanis M; Lenhardt T; Langguth P
Adv Drug Deliv Rev; 2007 Jul; 59(6):419-26. PubMed ID: 17566595
[TBL] [Abstract][Full Text] [Related]
2. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
Guivarc'h PH; Vachon MG; Fordyce D
Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
Hu L; Tang X; Cui F
J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
[TBL] [Abstract][Full Text] [Related]
4. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt.
Chen Y; Lu Y; Chen J; Lai J; Sun J; Hu F; Wu W
Int J Pharm; 2009 Jul; 376(1-2):153-60. PubMed ID: 19394416
[TBL] [Abstract][Full Text] [Related]
5. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
Mou D; Chen H; Wan J; Xu H; Yang X
Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
[TBL] [Abstract][Full Text] [Related]
6. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.
Chattopadhyay P; Shekunov BY; Yim D; Cipolla D; Boyd B; Farr S
Adv Drug Deliv Rev; 2007 Jul; 59(6):444-53. PubMed ID: 17582648
[TBL] [Abstract][Full Text] [Related]
7. Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development.
Sigfridsson K; Lundqvist AJ; Strimfors M
Drug Dev Ind Pharm; 2009 Dec; 35(12):1479-86. PubMed ID: 19929207
[TBL] [Abstract][Full Text] [Related]
8. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the gastrointestinal absorption and bioavailability of fenofibrate and fenofibric acid in humans.
Zhu T; Ansquer JC; Kelly MT; Sleep DJ; Pradhan RS
J Clin Pharmacol; 2010 Aug; 50(8):914-21. PubMed ID: 20145261
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
Manjunath K; Venkateswarlu V
J Control Release; 2005 Oct; 107(2):215-28. PubMed ID: 16014318
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies.
Sant VP; Smith D; Leroux JC
J Control Release; 2005 May; 104(2):289-300. PubMed ID: 15907580
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
Kocbek P; Baumgartner S; Kristl J
Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459
[TBL] [Abstract][Full Text] [Related]
13. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
Tan A; Simovic S; Davey AK; Rades T; Prestidge CA
J Control Release; 2009 Feb; 134(1):62-70. PubMed ID: 19013488
[TBL] [Abstract][Full Text] [Related]
14. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.
Kayaert P; Li B; Jimidar I; Rombaut P; Ahssini F; Van den Mooter G
Eur J Pharm Biopharm; 2010 Nov; 76(3):507-13. PubMed ID: 20887787
[TBL] [Abstract][Full Text] [Related]
15. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP
Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303
[TBL] [Abstract][Full Text] [Related]
16. Bioadhesion and enhanced bioavailability by wheat germ agglutinin-grafted lipid nanoparticles for oral delivery of poorly water-soluble drug bufalin.
Liu Y; Wang P; Sun C; Zhao J; Du Y; Shi F; Feng N
Int J Pharm; 2011 Oct; 419(1-2):260-5. PubMed ID: 21816211
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
[TBL] [Abstract][Full Text] [Related]
18. Use of hydrophobins in formulation of water insoluble drugs for oral administration.
Haas Jimoh Akanbi M; Post E; Meter-Arkema A; Rink R; Robillard GT; Wang X; Wösten HA; Scholtmeijer K
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):526-31. PubMed ID: 19836932
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
20. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
